Tags

Type your tag names separated by a space and hit enter

Comparison between efficacy of full- and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis.
Ophthalmologica. 1993; 207(3):144-7.O

Abstract

The study enrolled 59 eyes with rubeosis iridis and proliferative diabetic retinopathy. The efficacies of two types of panretinal photocoagulation ('full' and 'mild' scatter) on the course of diabetic rubeosis iridis were compared. The mean posttreatment follow-up period was 22 +/- 4.8 months. After application of full-scatter photocoagulation (1,200-1,600 spots) in 27 eyes, rubeosis iridis regressed in 70.4% cases, remained unchanged in 14.8% and deteriorated in 14.8%. After mild-scatter photo-coagulation (400-650 spots) in 32 treated eyes, rubeosis iridis regressed in 37.5% cases, 34.4% was unchanged, while deterioration was found in 28.1%. A better therapeutic effect of panretinal photocoagulation in regression of diabetic rubeosis iridis was obtained, if the total dose of the applied laser spots was higher.

Links

Publisher Full Text

Authors+Show Affiliations

Striga M
Department of Ophthalmology, Sestre milosrdnice University Hospital, Zagreb, Croatia.
Ivanisević M
No affiliation info available

MeSH

AdultAgedDiabetic RetinopathyFemaleFollow-Up StudiesHumansIrisLight CoagulationMaleMiddle AgedNeovascularization, PathologicPrognosis

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

7506403

Citation

Striga, M, and M Ivanisević. "Comparison Between Efficacy of Full- and Mild-scatter (panretinal) Photocoagulation On the Course of Diabetic Rubeosis Iridis." Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde, vol. 207, no. 3, 1993, pp. 144-7.
Striga M, Ivanisević M. Comparison between efficacy of full- and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis. Ophthalmologica. 1993;207(3):144-7.
Striga, M., & Ivanisević, M. (1993). Comparison between efficacy of full- and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis. Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde, 207(3), 144-7.
Striga M, Ivanisević M. Comparison Between Efficacy of Full- and Mild-scatter (panretinal) Photocoagulation On the Course of Diabetic Rubeosis Iridis. Ophthalmologica. 1993;207(3):144-7. PubMed PMID: 7506403.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison between efficacy of full- and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis. AU - Striga,M, AU - Ivanisević,M, PY - 1993/1/1/pubmed PY - 1993/1/1/medline PY - 1993/1/1/entrez SP - 144 EP - 7 JF - Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde JO - Ophthalmologica VL - 207 IS - 3 N2 - The study enrolled 59 eyes with rubeosis iridis and proliferative diabetic retinopathy. The efficacies of two types of panretinal photocoagulation ('full' and 'mild' scatter) on the course of diabetic rubeosis iridis were compared. The mean posttreatment follow-up period was 22 +/- 4.8 months. After application of full-scatter photocoagulation (1,200-1,600 spots) in 27 eyes, rubeosis iridis regressed in 70.4% cases, remained unchanged in 14.8% and deteriorated in 14.8%. After mild-scatter photo-coagulation (400-650 spots) in 32 treated eyes, rubeosis iridis regressed in 37.5% cases, 34.4% was unchanged, while deterioration was found in 28.1%. A better therapeutic effect of panretinal photocoagulation in regression of diabetic rubeosis iridis was obtained, if the total dose of the applied laser spots was higher. SN - 0030-3755 UR - https://www.unboundmedicine.com/medline/citation/7506403/Comparison_between_efficacy_of_full__and_mild_scatter__panretinal__photocoagulation_on_the_course_of_diabetic_rubeosis_iridis_ L2 - https://www.karger.com?DOI=10.1159/000310421 DB - PRIME DP - Unbound Medicine ER -